You may have heard emergency contraception referred to as the morning-after pill, or brand names such as Plan B and ella. Emergency contraception is a term used for drugs taken after sex with the intent to prevent pregnancy. There are different brands of emergency contraception available, but the most common in America are Plan B One-Step and ella. Many confuse emergency contraception with the abortion pill. The abortion pill terminates an established pregnancy. Emergency contraception, on the other hand, works primarily by preventing conception (though in some cases it has the potential to cause a very early abortion). If you have questions about emergency contraception, we are here to help you. We’re just a phone call away.
[1]“Plan B One-Step Prescribing Information: Mechanism of Action,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[2]“Plan B One-Step Prescribing Information: Indications and Usage,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[3]“Plan B One-Step Prescribing Information: Clinical Trials Experience,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[4]“Plan B One-Step Prescribing Information: Contraindications,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf and “Plan B One-Step Prescribing Information: Indications and Usage,” Barr Pharmaceuticals, last modified August 2009, http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[5]“Plan B One-Step Prescribing Information: Ectopic Pregnancy,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[6]“Plan B One-Step Prescribing Information: Clinical Studies,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[7]“Plan B One-Step Prescribing Information: Drug Abuse and Dependence,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[8]“Plan B One-Step Prescribing Information: Overdose,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[9]“Plan B One-Step Prescribing Information: Specific Populations/Pediatric,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[10]“Plan B One-Step Prescribing Information: Specific Populations/Geriatric,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[11]“Plan B One-Step Prescribing Information: Specific Populations/Hepatic Impairment,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[12]“Plan B One-Step Prescribing Information: Specific Populations/Renal Impairment,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[13]“Plan B One-Step Prescribing Information: Drug-Drug Interactions,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[14]“Plan B One-Step Prescribing Information: Specific Populations/Race,” Barr Pharmaceuticals, last modified August 2009,http://www.planbonestep.com/pdf/PlanBOneStepFullProductInformation.pdf[15]“ella Prescribing Information: Open-Label Study,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E[16]“ella Prescribing Information: Mechanism of Action,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E[17]Donna J. Harrison and James G. Mitroka, “Defining Reality: The Potential Role of Pharmacists in Assessing the Impact of Progesterone Receptor Modulators and Misoprostol in Reproductive Health,” The Annals of Pharmacotherapy 45, (January 2011): 115.[18]Ibid.[19]“ella Prescribing Information: Adverse Reactions,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E[20]“ella Prescribing Information: Open-Label Study,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E[21]“ella Prescribing Information: Fertility Following Use,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E[22]“ella Prescribing Information: Contraindications,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E[23]“ella Prescribing Information: Repeated Use,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E[24]“ella Prescribing Information: Nursing Mothers,” Watson Pharma, last modified April 2012, http://pi.watson.com/data_stream.asp?product_group=1699&p=pi&language=E